FATE R&D to Revenue
Fate Therapeutics Inc · R&D to Revenue
FATE R&D to Revenue
Latest reported1622.46%period ending
FATE FY R&D/Revenue (842.56% → 1622.46%)
Latest values, visible window
High-resolution chart · PNG
FATE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1,622.4646% | |
| 990.3969% | |
| 271.6635% | |
| 332.7664% | |
| 385.9166% | |
| 399.6405% | |
| 821.8165% | |
| 1,181.9409% | |
| 836.7755% | |
| 600.9087% | |
| 816.9889% | |
| 0% | |
| 1,236.5602% | |
| 449.4007% | |
| 842.5641% |